https://www.aigom.it/wp-content/uploads/2026/06/ART30.6.png645450Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-06-30 13:51:182026-06-30 13:51:18OPPORTUNISTIC SALPINGECTOMY FOR PREVENTION OF TUBO-OVARIAN CARCINOMA: THE EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY CONSENSUS STATEMENTS.
https://www.aigom.it/wp-content/uploads/2026/06/ART23.1.png714450Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-06-23 06:35:132026-06-23 06:35:13THE PATHOLOGIC RESPONSE EVALUATION AND DETECTION IN CIRCULATING TUMOR-DNA STUDY: ULTRASENSITIVE CIRCULATING TUMOR-DNA ASSESSMENT OF BREAST CANCER MINIMAL RESIDUAL DISEASE.
https://www.aigom.it/wp-content/uploads/2026/06/ART9.6.png501400Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-06-09 09:50:562026-06-09 09:50:56FINAL ANALYSIS RESULTS AND PATIENT-REPORTED OUTCOMES FROM DESTINY-LUNG02-A DOSE-BLINDED, RANDOMIZED, PHASE 2 STUDY OF TRASTUZUMAB DERUXTECAN IN PATIENTS WITH HER2-MUTANT METASTATIC NSCLC
